331 related articles for article (PubMed ID: 23171584)
1. Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery.
Marzano AV; Ishak RS; Colombo A; Caroli F; Crosti C
Dermatology; 2012; 225(3):215-9. PubMed ID: 23171584
[TBL] [Abstract][Full Text] [Related]
2. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)--a new autoinflammatory syndrome distinct from PAPA syndrome.
Braun-Falco M; Kovnerystyy O; Lohse P; Ruzicka T
J Am Acad Dermatol; 2012 Mar; 66(3):409-15. PubMed ID: 21745697
[TBL] [Abstract][Full Text] [Related]
3. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy.
Bruzzese V
J Clin Rheumatol; 2012 Dec; 18(8):413-5. PubMed ID: 23188209
[TBL] [Abstract][Full Text] [Related]
4. Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab.
De Wet J; Jordaan HF; Kannenberg SM; Tod B; Glanzmann B; Visser WI
Dermatol Online J; 2017 Dec; 23(12):. PubMed ID: 29447652
[TBL] [Abstract][Full Text] [Related]
5. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
Scheinfeld N
Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
[TBL] [Abstract][Full Text] [Related]
6. Genetic mutations in pyoderma gangrenosum, hidradenitis suppurativa, and associated autoinflammatory syndromes: Insights into pathogenic mechanisms and shared pathways.
Satoh TK
J Dermatol; 2024 Feb; 51(2):160-171. PubMed ID: 38031879
[TBL] [Abstract][Full Text] [Related]
7. Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation.
Marzano AV; Borghi A; Meroni PL; Cugno M
Br J Dermatol; 2016 Nov; 175(5):882-891. PubMed ID: 27106250
[TBL] [Abstract][Full Text] [Related]
8. Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne.
Vinkel C; Thomsen SF
Int J Dermatol; 2017 Aug; 56(8):811-818. PubMed ID: 28345207
[TBL] [Abstract][Full Text] [Related]
9. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis).
Marzano AV; Damiani G; Ceccherini I; Berti E; Gattorno M; Cugno M
Br J Dermatol; 2017 Jun; 176(6):1588-1598. PubMed ID: 27943240
[TBL] [Abstract][Full Text] [Related]
10. Pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) and polycystic ovary syndrome: Coincidentally or aetiologically connected?
Zivanovic D; Masirevic I; Ruzicka T; Braun-Falco M; Nikolic M
Australas J Dermatol; 2017 May; 58(2):e54-e59. PubMed ID: 26831949
[TBL] [Abstract][Full Text] [Related]
11. Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome: A Case Report and Literature Review.
Huang J; Tsang LS; Shi W; Li J
Front Med (Lausanne); 2022; 9():856786. PubMed ID: 35402426
[TBL] [Abstract][Full Text] [Related]
12. Hidradenitis Suppurativa-Related Autoinflammatory Syndromes: An Updated Review on the Clinics, Genetics, and Treatment of Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PASH), Pyogenic Arthritis, Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PAPASH), Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis (SAPHO), and Rarer Forms.
Maronese CA; Moltrasio C; Marzano AV
Dermatol Clin; 2024 Apr; 42(2):247-265. PubMed ID: 38423685
[TBL] [Abstract][Full Text] [Related]
13. Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases.
Marzano AV; Ceccherini I; Gattorno M; Fanoni D; Caroli F; Rusmini M; Grossi A; De Simone C; Borghi OM; Meroni PL; Crosti C; Cugno M
Medicine (Baltimore); 2014 Dec; 93(27):e187. PubMed ID: 25501066
[TBL] [Abstract][Full Text] [Related]
14. Successful use of adalimumab to treat pyoderma gangrenosum, acne and suppurative hidradenitis (PASH syndrome) following colectomy in ulcerative colitis.
Murphy B; Morrison G; Podmore P
Int J Colorectal Dis; 2015 Aug; 30(8):1139-40. PubMed ID: 25564349
[No Abstract] [Full Text] [Related]
15. PsAPASH: a rare and recent autoinflammatory syndrome associated with hidradenitis suppurativa.
Gadelha RL; Paiva RDSR; Palitot EB; Costa JEFD
An Bras Dermatol; 2020; 95(2):203-206. PubMed ID: 32063421
[TBL] [Abstract][Full Text] [Related]
16. PAPA, PASH and PAPASH Syndromes: Pathophysiology, Presentation and Treatment.
Cugno M; Borghi A; Marzano AV
Am J Clin Dermatol; 2017 Aug; 18(4):555-562. PubMed ID: 28236224
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone.
Staub J; Pfannschmidt N; Strohal R; Braun-Falco M; Lohse P; Goerdt S; Leverkus M
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2243-7. PubMed ID: 25352307
[TBL] [Abstract][Full Text] [Related]
18. Pyogenic Arthritis, Pyoderma Gangrenosum, Acne, Suppurative Hidradenitis (PA-PASH) Syndrome: An Atypical Presentation of a Rare Syndrome.
Ursani MA; Appleyard J; Whiteru O
Am J Case Rep; 2016 Aug; 17():587-91. PubMed ID: 27530224
[TBL] [Abstract][Full Text] [Related]
19. Tumor Necrosis Factor Antagonists in the Treatment of Pyoderma Gangrenosum, Acne, and Suppurative Hidradenitis (PASH) Syndrome.
Saint-Georges V; Peternel S; Kaštelan M; Brajac I
Acta Dermatovenerol Croat; 2018 Jun; 26(2):173-178. PubMed ID: 29989876
[TBL] [Abstract][Full Text] [Related]
20. PAPA spectrum disorders.
Genovese G; Moltrasio C; Garcovich S; Marzano AV
G Ital Dermatol Venereol; 2020 Oct; 155(5):542-550. PubMed ID: 32618443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
